- Vaccine Name: BEXSERO
- Target Pathogen: Neisseria meningitidis
- Target Disease: Meningitis
- Product Name: Meningococcal Group B Vaccine
- Tradename: BEXSERO
- Manufacturer: Novartis Vaccines and Diagnostics, Inc
- CDC CVX code: 163
- Type: Subunit vaccine
- Status: Licensed
- Location Licensed: USA, Canada
- Host Species for Licensed Use: Human
- Allergen: Latex
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2°C to 8°C (36°F to 46°F), do not freeze, and keep away from light.
- Approved Age for Licensed Use: 10 to 25 years of age.
- Description: BEXSERO (Meningococcal Group B Vaccine) is a sterile, white, opalescent, suspension for intramuscular injection. Each 0.5 mL dose of BEXSERO is formulated to contain 50 micrograms each of recombinant proteins Neisserial adhesin A (NadA), Neisserial Heparin Binding Antigen (NHBA), and factor H binding protein (fHbp), 25 micrograms of Outer Membrane Vesicles (OMV), 1.5 mg aluminum hydroxide (0.519 mg of Al3+), 3.125 mg sodium chloride, 0.776 mg histidine, and 10 mg sucrose at pH 6.4 – 6.7.(FDA: BEXSERO)
|
